These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2151400)

  • 1. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine.
    Ujike H; Akiyama K; Otsuki S
    Psychopharmacology (Berl); 1990; 102(4):459-64. PubMed ID: 2151400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS; Jones DN; Holtzman SG; Juncos JL; Kalivas PW; Justice JB
    Psychopharmacology (Berl); 1994 Oct; 116(2):217-25. PubMed ID: 7862951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 104(2):201-7. PubMed ID: 1831560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C; Bédard PJ
    Neuropharmacology; 1988 Dec; 27(12):1257-64. PubMed ID: 2907616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.
    Barrett RL; Appel JB
    Psychopharmacology (Berl); 1989; 99(1):13-6. PubMed ID: 2528777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.
    Witkin JM; Schindler CW; Tella SR; Goldberg SR
    Psychopharmacology (Berl); 1991; 104(4):425-31. PubMed ID: 1838199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
    Asin KE; Bednarz LM
    Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.